Cangrelor Patent Expiration
Cangrelor was first introduced by Chiesi Usa Inc
Cangrelor Patents
Given below is the list of patents protecting Cangrelor, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Kengreal | US10039780 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Jul 10, 2035 | Chiesi |
Kengreal | US6114313 | Pharmaceutical compositions for freeze drying |
Dec 11, 2018
(Expired) | Chiesi |
Kengreal | US6130208 | Formulation containing a nucleotide analogue |
Jun 29, 2023
(Expired) | Chiesi |
Kengreal | US8680052 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | Mar 09, 2033 | Chiesi |
Kengreal | US8759316 | Maintenance of platelet inhibition during antiplatelet therapy | May 13, 2029 | Chiesi |
Kengreal | US9295687 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Jul 10, 2035 | Chiesi |
Kengreal | US9427448 | Methods of treating, reducing the incidence of, and/or preventing ischemic events | Nov 10, 2030 | Chiesi |
Kengreal | US9439921 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Jul 10, 2035 | Chiesi |
Kengreal | US9700575 | Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same | Jul 10, 2035 | Chiesi |
Kengreal | US9925265 | Methods of treating or preventing stent thrombosis | May 13, 2029 | Chiesi |
Coming Soon
Patent Strength Analyzer
![](/_nuxt/img/PatentAnalyzerAd.722976d.jpg)
YesNo
Thank you for your response 🥳